These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 26903473)
1. Small synthetic ligands for the enrichment of viral particles pseudotyped with amphotropic murine leukemia virus envelope. Fernandes CS; Castro R; Coroadinha AS; Roque AC J Chromatogr A; 2016 Mar; 1438():160-70. PubMed ID: 26903473 [TBL] [Abstract][Full Text] [Related]
2. Retroviral particles are effectively purified on an affinity matrix containing peptides selected by phage-display. Fernandes CS; Barbosa I; Castro R; Pina AS; Coroadinha AS; Barbas A; Roque AC Biotechnol J; 2016 Dec; 11(12):1513-1524. PubMed ID: 27491899 [TBL] [Abstract][Full Text] [Related]
3. Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. Guibinga GH; Miyanohara A; Esko JD; Friedmann T Mol Ther; 2002 May; 5(5 Pt 1):538-46. PubMed ID: 11991744 [TBL] [Abstract][Full Text] [Related]
4. Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications. Transfiguracion J; Jaalouk DE; Ghani K; Galipeau J; Kamen A Hum Gene Ther; 2003 Aug; 14(12):1139-53. PubMed ID: 12908966 [TBL] [Abstract][Full Text] [Related]
5. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts. Arai T; Takada M; Ui M; Iba H Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362 [TBL] [Abstract][Full Text] [Related]
6. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein. Zavorotinskaya T; Albritton LM Mol Ther; 2001 Mar; 3(3):323-8. PubMed ID: 11273774 [TBL] [Abstract][Full Text] [Related]
7. Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration. Zimmermann K; Scheibe O; Kocourek A; Muelich J; Jurkiewicz E; Pfeifer A BMC Biotechnol; 2011 May; 11():55. PubMed ID: 21599966 [TBL] [Abstract][Full Text] [Related]
8. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein. Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830 [TBL] [Abstract][Full Text] [Related]
10. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein. Lin AH; Kasahara N; Wu W; Stripecke R; Empig CL; Anderson WF; Cannon PM Hum Gene Ther; 2001 Mar; 12(4):323-32. PubMed ID: 11242525 [TBL] [Abstract][Full Text] [Related]
11. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients. Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618 [TBL] [Abstract][Full Text] [Related]
12. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery. Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185 [TBL] [Abstract][Full Text] [Related]
13. Engraftment of NOD/SCID mice with human CD34(+) cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Gatlin J; Melkus MW; Padgett A; Kelly PF; Garcia JV J Virol; 2001 Oct; 75(20):9995-9. PubMed ID: 11559834 [TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated targeting of replication-competent retroviral vectors. Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141 [TBL] [Abstract][Full Text] [Related]
15. Scaleable purification process for gene therapy retroviral vectors. Rodrigues T; Carvalho A; Carmo M; Carrondo MJ; Alves PM; Cruz PE J Gene Med; 2007 Apr; 9(4):233-43. PubMed ID: 17428003 [TBL] [Abstract][Full Text] [Related]
16. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Segura MM; Kamen A; Trudel P; Garnier A Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800 [TBL] [Abstract][Full Text] [Related]
17. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Yang Y; Vanin EF; Whitt MA; Fornerod M; Zwart R; Schneiderman RD; Grosveld G; Nienhuis AW Hum Gene Ther; 1995 Sep; 6(9):1203-13. PubMed ID: 8527479 [TBL] [Abstract][Full Text] [Related]
18. Rational development of two flowthrough purification strategies for adenovirus type 5 and retro virus-like particles. Nestola P; Peixoto C; Villain L; Alves PM; Carrondo MJ; Mota JP J Chromatogr A; 2015 Dec; 1426():91-101. PubMed ID: 26643723 [TBL] [Abstract][Full Text] [Related]
19. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope. Lam JS; Reeves ME; Cowherd R; Rosenberg SA; Hwu P Hum Gene Ther; 1996 Aug; 7(12):1415-22. PubMed ID: 8844200 [TBL] [Abstract][Full Text] [Related]
20. Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Hanawa H; Kelly PF; Nathwani AC; Persons DA; Vandergriff JA; Hargrove P; Vanin EF; Nienhuis AW Mol Ther; 2002 Mar; 5(3):242-51. PubMed ID: 11863413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]